Plivensia

sirukumab · Janssen-Cilag International NV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Plivensia, covering 2017-11-10 to 2017-11-10. Get the full timeline:

Most recent: EMA Application withdrawn: Plivensia (sirukumab) — Janssen-Cilag International NV